Thyroid disease

Predawn Versus Preiftar Timing of Levothyroxine Administration During Ramadan Intermittent Fasting: A Multicenter Randomized Controlled Trial

Endocr PractPublished Randomised controlled trial

Authors' conclusion

Both preiftar and predawn LT4 regimens maintained thyroid stability during Ramadan. Either can be safely adopted according to patient preference.

Study context

Population
Adults with primary hypothyroidism (thyroid cancer excluded), 3 Saudi cities; mean age 49 ± 12 years, 87% femalecompleted the study
Participants
303 adults
Comparison
Preiftar vs predawn levothyroxine (LT4) dosing during Ramadan
  • Preiftarn = 156
  • Predawnn = 147
Methodological detailsmulticenter, open-label
  • Multicenter
  • Open-label

Primary result

As reported in the abstract

4 to 6 weeks after Ramadan
  • Within-group post-Ramadan changes were nonsignificant
  • Preiftar vs Predawn: P = 0.47
  • Preiftar vs Predawn: P = 0.81

Further findings

Weekly LT4 dose

P = 0.001

Thyroid-stimulating hormone (TSH), pre-Ramadan
P = 0.3
Free thyroxine (FT4), pre-Ramadan
P = 0.16
TSH, post-Ramadan
P = 0.78
FT4, post-Ramadan
P = 0.003

Within-group post-Ramadan changes

Within-group post-Ramadan changes were nonsignificant

Compliance and satisfaction

Compliance and satisfaction were comparable

Original publication

Predawn Versus Preiftar Timing of Levothyroxine Administration During Ramadan Intermittent Fasting: A Multicenter Randomized Controlled Trial. Endocr Pract. Published 31 January 2026. doi:10.1016/j.eprac.2026.01.008

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.